Evidence map›Paper›PMID 42328968›Full record

ArticleGlobal health action2026

The equity and effectiveness of China's 2009 folic acid supplementation programme for long-term child development.

Naiyuan Liang, Cheng Huang, Qiang Pan

Abstract read
In one paragraph

Article in Global health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Naiyuan LiangSchool of Economics and Management, Harbin Institute of Technology, Shenzhen, People's Republic of China.ORCID 0009-0003-2273-7417
Cheng HuangInstitute for Global Health and Development, Peking University, Beijing, People's Republic of China.ORCID 0009-0006-3262-1129
Qiang PanSchool of Economics and Management, Harbin Institute of Technology, Shenzhen, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaternal folic acid supplementation is a cornerstone of public health for preventing neural tube defects (NTDs), yet its long-term impact on child development remains underexplored.

objectiveThis study evaluates the long-term cognitive and mental health associations of maternal folic acid supplementation by utilising China's 2009 Folic Acid Supplementation Programme for rural women as a quasi-experimental framework.

methodsWe analysed 1,953 children aged 10-15 years from the 2020 China Family Panel Studies. Using provincial NTD prevalence in 2009 from the Maternal and Child Health Surveillance system as a proxy for intervention intensity, we employed difference-in-differences models to estimate associations, adjusting for demographic and parental covariates.

resultsMaternal folic acid supplementation was significantly associated with improved outcomes among girls: higher memory scores (

conclusionsThis study highlights sex-specific, long-term associations of maternal folic acid supplementation but reveals that socioeconomic disparities may constrain mental health gains. Thus, universal nutrition interventions alone may be insufficient to bridge health equity gaps. The findings should be interpreted within the broader nutritional ecology and alongside concurrent macro-social changes that shape child development outcomes.

Indexed as

Child DevelopmentDietary SupplementsFolic AcidNeural Tube DefectsAdolescentChildChinaFemaleHumansMalePregnancyRural PopulationSocioeconomic FactorsFolic Acidchild developmentFolic acid supplementationhealth equityquasi-experimental designsocioeconomic status

Identifiers

PMID42328968
PMCPMC13288903

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.